Form D Explorer

Form 1-K — Nok Therapeutics, Inc.

0001213900-25-040030 · filed May 6, 2025

Offering

Total offering
—
Total sold
—
Security type
—
Price per security
—
Over-allotment
—
Jurisdictions
—

Issuer

CIK
2038166
Entity
Corporation
Jurisdiction
FLORIDA
Address
2009 MACKENZIE WAY
CRANBERRY TWP., PA 16066

Most recent fiscal year financials

Reg A+ Tier 2 financials are audited (1-A, 1-K). Tier 1 are reviewed.

Total assets
—
Total liabilities
—
Cash
—
Total revenues
—
Net income
—

Same issuer's Form D filings

View the original filing on SEC EDGAR ↗